Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
30 hedge funds and large institutions have $15.4M invested in Roivant Sciences Ltd. Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 31 → 30 (-1)
22% less capital invested
Capital invested by funds: $19.8M → $15.4M (-$4.44M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$285K |
| 2 |
CC
Centiva Capital
New York
|
+$106K |
| 3 |
Walleye Capital
New York
|
+$20.3K |
| 4 |
CAC
Cowen and Company
New York
|
+$13.1K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$1.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$52.7K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$15.1K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$15K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$11K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$4.49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAC
26
Cowen and Company
New York
| $10K | +$13.1K | +24,563 | New |
|
|
PCM
27
Prelude Capital Management
New York
| $9K | -$4.49K | -8,444 | -27% |
|
28
Walleye Trading
New York
| $4K | – | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $3K | -$109 | -205 | -3% |
|
|
WAM
30
Wolverine Asset Management
Chicago,
Illinois
| $2K | -$3.65K | -6,866 | -53% |
|
|
ECM
31
ExodusPoint Capital Management
New York
| – | -$15K | -24,563 | Closed |
|
|
OMC
32
Old Mission Capital
Chicago,
Illinois
| – | -$11K | -18,304 | Closed |
|
ROIVW Hedge Fund Activity: Q3 2022 in Review
30 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q3 2022, worth a combined $15.4M — down 22% from $19.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ROIVW and 1 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $285K. The largest seller was Magnetar Financial, cutting an estimated $52.7K.
- 30 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q3 2022, down from 31 in Q2 2022.
- Funds reported $15.4M of Roivant Sciences Ltd. Warrant stock for Q3 2022, down 22% quarter-over-quarter.
- 1 fund opened new Roivant Sciences Ltd. Warrant positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest Roivant Sciences Ltd. Warrant buyer in Q3 2022 was D.E. Shaw & Co, an estimated $285K added.
- The largest Roivant Sciences Ltd. Warrant seller in Q3 2022 was Magnetar Financial, an estimated $52.7K sold.
Based on aggregated 13F filings for Q3 2022.